Vitrolife Interim Report January - March 2011

GÖTEBORG, Sweden--(BUSINESS WIRE)-- The operating margin amounted to 12 (13) percent. Operating income amounted to SEK 10 (10) million, which corresponds to an increase of 1 percent. Operating income before research and development costs increased by 6 percent and amounted to SEK 22 (21) million.

MORE ON THIS TOPIC